000 | 01992 a2200553 4500 | ||
---|---|---|---|
005 | 20250515174726.0 | ||
264 | 0 | _c20091124 | |
008 | 200911s 0 0 eng d | ||
022 | _a1873-7064 | ||
024 | 7 |
_a10.1016/j.neuropharm.2009.06.010 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aXu, Ying | |
245 | 0 | 0 |
_aCurcumin reverses impaired cognition and neuronal plasticity induced by chronic stress. _h[electronic resource] |
260 |
_bNeuropharmacology _cSep 2009 |
||
300 |
_a463-71 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntidepressive Agents, Tricyclic _xpharmacology |
650 | 0 | 4 |
_aCalcium-Calmodulin-Dependent Protein Kinase Type 2 _xmetabolism |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCognition Disorders _xdrug therapy |
650 | 0 | 4 |
_aCorticosterone _xblood |
650 | 0 | 4 |
_aCurcumin _xadministration & dosage |
650 | 0 | 4 |
_aHippocampus _xdrug effects |
650 | 0 | 4 |
_aImipramine _xpharmacology |
650 | 0 | 4 |
_aLearning Disabilities _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMaze Learning _xdrug effects |
650 | 0 | 4 |
_aMemory Disorders _xdrug therapy |
650 | 0 | 4 |
_aNeuronal Plasticity _xdrug effects |
650 | 0 | 4 |
_aNeuroprotective Agents _xadministration & dosage |
650 | 0 | 4 |
_aPyramidal Cells _xcytology |
650 | 0 | 4 | _aRandom Allocation |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xmetabolism |
650 | 0 | 4 |
_aSpace Perception _xdrug effects |
650 | 0 | 4 |
_aStress, Psychological _xcomplications |
700 | 1 | _aLin, Dan | |
700 | 1 | _aLi, Shan | |
700 | 1 | _aLi, Gaowen | |
700 | 1 | _aShyamala, Subramaniam G | |
700 | 1 | _aBarish, Philip A | |
700 | 1 | _aVernon, Matthew M | |
700 | 1 | _aPan, Jianchun | |
700 | 1 | _aOgle, William O | |
773 | 0 |
_tNeuropharmacology _gvol. 57 _gno. 4 _gp. 463-71 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuropharm.2009.06.010 _zAvailable from publisher's website |
999 |
_c18959013 _d18959013 |